Skip to main content


What's new

On December 11, Orexigen announced the resubmission of its weight management drug Contrave (naltrexone/bupropion) to... Continue Reading »

James Hirsch assesses the implications for diabetes from the bestseller Salt Sugar Fat. Continue Reading »

Kelly on the shocking new data just released on diabetes costs and what we can do about it. Continue Reading »

What really causes weight gain? A fascinating review in the New England Journal of Medicine details myths and facts about obesity. Continue Reading »

The giant Consumer Electronics Show, held each January in Las Vegas, had a variety of devices relevant to diabetes... Continue Reading »

This month, in a surprise move, Vivus announced that its weight management medication Qsymia is now available via... Continue Reading »